drugset / Trial / NCT00962026

Rilonacept in Diabetes Mellitus Type 1: Safety Study

NCT00962026

Phase 1 Completed 13 enrolled University of Texas Southwestern Medical Center
NaSingle-groupOpen-labelTreatment

Summary

This study is being done to see if an investigational drug called rilonacept is safe to use in patients with type 1 diabetes, and if it can slow the loss of the body's ability to secrete insulin in patients who are still able to make a small amount of insulin.

Timeline

Start
2011-02
Primary completion
2013-03
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rilonacept Protein / enzyme biologic Subcutaneous